Mirum Pharmaceuticals, Inc(NASDAQ:MIRM) 
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial ...
Website: http://www.mirumpharma.com
Founded: 2018
Full Time Employees: 67
CEO: Christopher Peetz
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 42.15
H 43.03
L 41.30
C 42.03
V 641,574
10EMA 42.03
20EMA 42.03
60EMA 42.03
120EMA 42.03
250EMA 42.03